Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.
By G. Hütter, D. Nowak, M. Mossner, S. Ganepola, A. Müssig, Kristina Allers, T. Schneider, J. Hofmann, C. Kücherer, O. Blau and 3 more. New England Journal of Medicine, 2009
1,771 citations recorded by the source corpus.
Subfields: Immunology, Virology
View Paper: https://www.semanticscholar.org/paper/2715400b2b00e621c93ea85fad74ed9ffbe1d379
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Virology
Citations in the corpus
- Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T-cells (2012, background): “The safety and long term persistence of engineered T cells provides a further rationale for cell based HIV eradication strategies (38).”
- Zinc finger nuclease-mediated CCR5 knockout hematopoietic stem cell transplantation controls HIV-1 in vivo (2010, neutral): “It may also be possible to incorporate ART treatment interruptions into an overall therapeutic strategy, as recently described for HIV-infected individuals receiving autologous HSC engineered with anti-HIV ribozymes, where gene marked progeny were found at higher levels in patients who underwent tre”
- International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors (2014, neutral): “…in 2008, the patient was transplanted with hematopoietic stem cells from an HLAmatched donor homozygous for CCR5D32 and has had no PCR-detectable virus in blood or tissue since then off antiretroviral therapy, suggesting that viral reservoirs may have been eliminated (Hutter et al., 2009).”